PHARMACY

ADA, Lilly USA want African-Americans to be victorious over diabetes

BY Allison Cerra

ATLANTA The American Diabetes Association, in association with Lilly USA, is hosting a free communitywide event in Atlanta, offering diabetes education, health screenings and a special performance by R&B singer Angie Stone.

The 11th annual Victory Over Diabetes event kicks off in Atlanta on Aug. 29, featuring singer-songwriter Angie Stone and Lilly USA’s Fearless African-Americans Connected and Empowered Diabetes campaign. This free day-long event, also supported by Aetna, educates and empowers African-Americans living with diabetes to better manage the disease by providing educational tools and culturally relevant resources.

Victory Over Diabetes will take place at the Georgia International Convention Center, and will feature: a series of diabetes-focused workshops, keynote speakers, free health screenings, “Fearlessly Fit with Diabetes” special session featuring Angie Stone, highlighting the importance of physical activity as part of overall diabetes management. Additionally, a $50,000 check will be presentated by corporate sponsor Aetna in support of the Atlanta ADA’s African-American-focused initiatives.

Through this event, the Atlanta ADA and the F.A.C.E. Diabetes campaign aim to raise awareness about the diabetes epidemic facing the African-American community. The disease affects more than 3 million African-Americans nationwide and African-Americans are 1.6 times more likely to have diabetes as non-Hispanic whites, according to statistics. As the national spokesperson for the F.A.C.E. Diabetes campaign, Grammy-nominated singer Angie Stone has been traveling to cities around the country, including Atlanta, since 2007 to inspire others by sharing how she personally manages the day-to-day challenges of living with diabetes.

“I’m thrilled to bring the F.A.C.E. Diabetes movement back to my hometown of Atlanta as part of Victory Over Diabetes,” said Stone. “Due, in part, to what I’ve learned through the campaign, I’ve made some great strides in better managing my own diabetes. I hope my story can motivate others, which is why I’m encouraging everyone to come out to this free event.”

“Lilly is excited to continue the momentum of the F.A.C.E. Diabetes campaign here in Atlanta by joining forces with the American Diabetes Association, the leading advocacy organization for diabetes,” said Bertika Quintero, manager Lilly Diabetes Outreach Initiatives, Lilly USA. “The F.A.C.E. Diabetes campaign was developed from in-depth research of African-Americans with diabetes and insights from health advocacy organizations including the ADA. By combining our resources and collective commitment, together, we can provide African-Americans with Type 2 diabetes the support they need to lead healthier lives.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves Ranbaxy’s generic peptic ulcer treatment

BY Alaric DeArment

PRINCETON, N.J. The Food and Drug Administration has given an India-based drug maker final approval to market a generic drug for treating peptic ulcer.

Ranbaxy Pharmaceuticals, a U.S. subsidiary of Ranbaxy Labs, announced Monday the approval of glycopyrrolate tablets in the 1-mg and 2-mg strengths. The drug is a generic version of Sciele Pharma’s Robinul and Robinul Forte tablets, respectively.

“We are pleased to receive this final approval for glycopyrrolate tablets,” Ranbaxy Pharmaceuticals VP sales and distribution Jim Meehan said in a statement.

Meehan said the drug would be launched between October and December. Glycopyrrolate tablets had sales of $26 million during the 12-month period ending in June, according to IMS Health data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Supervalu EVP joins NACDS board of directors

BY Allison Cerra

ALEXANDRIA, Va. An organization catering to the retail pharmacy industry has elected a new member to its board.

The National Association of Chain Drug Stores announced that Duncan Mac Naughton, EVP merchandising and marketing for Supervalu, was elected to the board of directors, effective Aug. 14. Mac Naughton will fill the position vacated by Kevin Tripp, who recently retired as Supervalu’s EVP of its retail Midwest division.

Mac Naughton will serve the remainder of the 2009-2010 term until April 2010, when the annual board of directors elections are held at the NACDS Annual Meeting.

Mac Naughton has a career of service within the supermarket industry. He has served on SUPERVALU’s executive team since joining the company in 2006 upon its acquisition of Albertsons, where Mac Naughton had served as executive vice president of merchandising. Prior to Albertsons, he served in key leadership roles at H-E-B and Kraft Foods.

“We are pleased to welcome Duncan to the NACDS Board of Directors,” said NACDS president and CEO Steve Anderson. “NACDS’ diverse membership is well-represented by the NACDS Board of Directors. Duncan brings leadership and expertise on behalf of the supermarket segment, and we look forward to working together to advance pharmacy as the face of neighborhood healthcare and to add value to NACDS’ engagement in front-end activities.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?